Aduro Clean Technologies Selected to Present at Chemelot Circular Hub Event in the Netherlands
May 09, 2024 07:00 ET
|
Aduro Clean Technologies Inc.
Aduro is pleased to announce its participation in the upcoming Chemelot Circular Hub event on May 15, 2024, at the Brightlands Chemelot Campus
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab reported on major progress in Q1 2024, including that it is on track to report Phase 2 PSC topline data at midyear 2024
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024 07:00 ET
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics today reported business highlights and financial results for the first quarter ending March 31, 2024.
Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conference on May 14, 2024
May 09, 2024 07:00 ET
|
Lantronix, Inc.
Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conference on May 14, 2024
Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline
May 09, 2024 07:00 ET
|
Bluejay Therapeutics
SAN MATEO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a leader in the development of novel therapeutics, today announced the successful closure of a $182 million Series C...
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
May 09, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO®...
Applied Therapeutics Reports First Quarter 2024 Financial Results
May 09, 2024 07:00 ET
|
Applied Therapeutics
Govorestat NDA for Classic Galactosemia under Priority Review, PDUFA target action date of November 28, 2024 Govorestat MAA under review by EMA; Day 120 3-month clock-stop extension granted; decision...
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
May 09, 2024 07:00 ET
|
Verona Pharma plc
Non-dilutive funding will support planned US commercial launch and expansion of ensifentrine’s clinical activities Cash runway extended beyond 2026 LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE...
The Judge Group Launches Center of Excellence to Accelerate Virtual Model Development of Arm-based Hardware Platforms
May 09, 2024 07:00 ET
|
The Judge Group
Judge announced the creation of a Center of Excellence, combining its technology consulting, staffing & training expertise with Arm Virtual Hardware.
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
May 09, 2024 07:00 ET
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund...
- May 09, 2024 07:19 ET United States $57.72 Bn Solar Energy Panel Market Competition, Forecast & Opportunities, 2019-2023 & 2024-2029: Increasing Emphasis on Energy Storage Solutions & Integration of AI and Data Analytics
- May 09, 2024 07:18 ET Absorbent Paper Market Insights and Forecast 2024-2034 Featuring Analysis of International Paper, Georgia-Pacific, Essity Aktiebolag, Metso, Ahlstrom